USPTO 2015–2025 USPTO PatentsView US Corporation

Cephea Valve Technologies, Inc.

USPTO PatentsView assignee record - 62 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cephea ranks #5,504 of 49,997 tracked US assignees by granted-patent volume, with 62 patents across 5 technology areas.

#5,504
of 49,997 US assignees by volume
Top 44%
by Innovation Score (37.4/100)
17.0
avg claims per patent
+309%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5504 · US Corporation #5,504 · 62 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 62 grants
  • UPPER-Q #5,504/49,997
  • PHOTO-FINISH Brio Water Technology
  • CPC-NARROW A61F · 5 areas
  • INNOV-THIN 37.4/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +309% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Brio Water Technology, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cephea’s 37.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cephea

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cephea's Innovation Score is 37.4/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cephea?

Each dot is one of Cephea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cephea’s own 17.0 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cephea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 61.962.062.06262.062.062.1 0102030 Granted patents (volume) Avg claims / patent Brio Water Technology, Inc. - 62, 2.06Brio Water Techno…C/HCA, Inc. - 62, 19C/HCAChemtreat, Inc. - 62, 17.74ChemtreatCaavo Inc - 62, 18.65CaavoCleerly, Inc. - 62, 26.4CleerlyDspace GMBH - 62, 12.95DspaceEgnyte, Inc. - 62, 22.23EgnyteEvident Corporation - 62, 17.79EvidentCephea Valve Technologies, Inc. - 62, 17.03Cephea Valve
Cephea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cephea's grants concentrate

Cephea Valve Technologies, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 95.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (13 grants) versus a trough of 2 in 2016. By volume, Cephea sits between Brio Water Technology, Inc. and Evident Corporation.

Cephea's three-year grant acceleration

From 2019–2021 to 2022–2024, Cephea Valve Technologies, Inc. moved from 28 to 21 grants (0.75x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Cephea's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cephea holds 62 patents at rank #5,506, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cephea

By rank, the assignees closest to #5,506 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Cephea's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cephea, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Cephea ranks #97 of 3,082 assignees by patent count in that subclass.

Cephea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Cephea Valve Technologies, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 3.2%
2017 2 3.2%
2018 3 4.8%
2019 4 6.5%
2020 13 21.0%
2021 11 17.7%
2022 6 9.7%
2023 11 17.7%
2024 4 6.5%
2025partial year 6 9.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cephea Valve Technologies, Inc.'s patent record in context - here's where to go next.

  • Cephea Valve Technologies, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 95.2% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #5,504 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cephea Valve Technologies, Inc. against Brio Water Technology, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.